Skeletal muscle serves as a paradigm for the acquisition of cell fate, yet the relationship between primitive cell populations and emerging myoblasts has remained elusive. We identify a novel population of resident Pax3 + / Pax7 + , muscle marker-negative cells throughout development. Using mouse mutants that uncouple myogenic progression, we show that these Pax + cells give rise to muscle progenitors. In the absence of skeletal muscle, they apoptose after down-regulation of Pax7. Furthermore, they mark the emergence of satellite cells during fetal development, and do not require Pax3 function. These findings identify critical cell populations during lineage restriction, and provide a framework for defining myogenic cell states for therapeutic studies. An unresolved issue in skeletal muscle development has been the nature of a reserve population of undifferentiated cells that ensures continued prenatal growth of this tissue (Parker et al. 2003; Tajbakhsh 2003) . In the early embryo, muscle progenitors and precursors have been described (Tajbakhsh and Buckingham 2000) . During post-natal life, satellite cells are the principal regenerative cell type (Zammit and Beauchamp 2001) . About 1 d before birth, the appearance of progenitors associated with fibers has led to the assumption that these cells will give rise to future satellite cells in the adult (Cossu et al. 1993) . However, the link between progenitors in the early somite and those observed at birth has remained enigmatic. In addition, the appearance of embryonic and fetal myoblasts has raised questions regarding their relationship with prenatal progenitors and emerging satellite cells. Studies in avians had suggested that satellite cells originate from somites, yet the endothelial origin of satellite cells remained unresolved (Armand et al. 1983) . Furthermore, recent observations that muscle-or bonemarrow-derived mesenchymal stem cells can give rise to satellite cells or contribute to adult muscle after injury has questioned the notion that satellite cells originate exclusively from somites (Ferrari et al. 1998; Asakura et al. 2002; LaBarge and Blau 2002; Polesskaya et al. 2003) . Therefore, in spite of considerable genetic data, cell relationships in the skeletal muscle lineage remain unresolved.
An unresolved issue in skeletal muscle development has been the nature of a reserve population of undifferentiated cells that ensures continued prenatal growth of this tissue (Parker et al. 2003; Tajbakhsh 2003) . In the early embryo, muscle progenitors and precursors have been described (Tajbakhsh and Buckingham 2000) . During post-natal life, satellite cells are the principal regenerative cell type (Zammit and Beauchamp 2001) . About 1 d before birth, the appearance of progenitors associated with fibers has led to the assumption that these cells will give rise to future satellite cells in the adult (Cossu et al. 1993) . However, the link between progenitors in the early somite and those observed at birth has remained enigmatic. In addition, the appearance of embryonic and fetal myoblasts has raised questions regarding their relationship with prenatal progenitors and emerging satellite cells. Studies in avians had suggested that satellite cells originate from somites, yet the endothelial origin of satellite cells remained unresolved (Armand et al. 1983) . Furthermore, recent observations that muscle-or bonemarrow-derived mesenchymal stem cells can give rise to satellite cells or contribute to adult muscle after injury has questioned the notion that satellite cells originate exclusively from somites (Ferrari et al. 1998; Asakura et al. 2002; LaBarge and Blau 2002; Polesskaya et al. 2003) . Therefore, in spite of considerable genetic data, cell relationships in the skeletal muscle lineage remain unresolved.
During embryonic development, transitory structures called somites give rise to an epithelial dermomyotome, the source of dermal and endothelial precursors, as well as all the skeletal muscles in the body (Christ and Ordahl 1995; Tajbakhsh and Buckingham 2000) . Multipotent muscle progenitor cells (MPCs) arising in the dermomyotome acquire definitive identity via the myogenic regulatory factors (MRFs) Myf5, Mrf4, and Myod (Rudnicki et al. 1993; Tajbakhsh et al. 1996; Kassar-Duchossoy et al. 2004 ). These progenitors give rise to muscle precursors called myoblasts (Hauschka 1994; Tajbakhsh 2003) . Muscle differentiation is subsequently mediated by Myogenin, Myod, and Mrf4 (Tajbakhsh and Buckingham 2000) . In the somite, the first skeletal muscle mass to form is the myotome. Skeletal muscle tissue is then established in successive steps by embryonic and fetal myoblasts that fuse to form differentiated primary and secondary fibers, respectively (Bonner and Hauschka 1974; Miller and Stockdale 1986; Cossu et al. 1988; Stockdale 1992; Pin and Merrifield 1993) . Embryonic and fetal myoblasts have been reported to have distinct properties (Cossu et al. 1988; Cusella-De Angelis et al. 1994 ); however, their exclusive contribution to primary and secondary fibers, respectively, has been questioned (Harris et al. 1989; Zhang and McLennan 1995; Dunglison et al. 1999) .
To address these issues, we examined genetic mutants that uncouple key steps during myogenic commitment, and at different stages of development. Our observations identify a novel population of cells that express Pax3 and Pax7 and reside in skeletal muscles of the trunk and limbs. Importantly, some do not express muscle markers, and by late fetal stages, they emerge as satellite cells.
Results and Discussion

Pax3/Pax7 and MRF expression identify distinct myogenic states in the somite
From embryonic day 9.75 (E9.75), almost all dermomyotomal cells express Pax3 and Pax7, although Pax3 is expressed at higher levels in the dorsal and ventral dermomyotome lips, whereas Pax7 is preferentially expressed in the central dermomyotome ( Fig. 1A,D ; Supplementary Fig. 1A,C) . Embryonic muscle progenitor cells (MP E Cs) are born predominantly along the dorsal and ventral dermomyotome lips (arrowheads in Fig. 1C [bottom], E). They express Myf5 and Mrf4 and rapidly give rise to Desmin + myoblasts that form the myotome in the somite (Tajbakhsh and Buckingham 2000) . A distinct topological distribution of Pax + and MRF + cells, in the dermomyotome and myotome, respectively, is characteris-tic of early myotome formation (Tajbakhsh 2003) . Pax3/ Pax7-expressing cells in the dermomyotome are cycling, whereas MRF-expressing cells in the myotome are predominantly post-mitotic (Supplementary Fig. 1C ; Kahane et al. 2001) .
Since other cell types including dermal and endothelial progenitors arise from the dermomyotome, it is not clear if all of the Pax-expressing cells located in this epithelium are the ancestors of MPCs (Christ and Ordahl 1995; Ben-Yair and Kalcheim 2005) . Pax3 and Pax7 protein levels normally decline after MRF expression and subsequent release of cells from the dermomyotome, since the majority of myotomal cells are Pax3/7 negative before E10.5 ( Fig. 1A ; Tajbakhsh et al. 1997 Supplementary Fig. 1A ). Pax3/7 proteins persist in these cells blocked dorsally and ventrally, indicating that the Pax + cells in these regions of the dermomyotome give rise to MP E Cs ( Fig. 1E; Supplementary Fig.  1A ). These findings, and the observation that a progressive loss of Pax expression was concomitant with a gain in ␤-gal expression in normal embryos ( Fig. 1D; (Fig. 1D,G) .
Immunohistochemistry of Myf5
nlacZ/+ embryos with anti-Pax7 and anti-␤-gal antibodies revealed that a subpopulation of these cells in the myotome remained Pax7 + /␤-gal − ( Fig. 1D ; Supplementary Fig. 1A ). This was confirmed with highly sensitive X-gal staining, which marks almost all myotomal cells (Cossu et al. 1996; Tajbakhsh et al. 1996 ; data not shown). Accordingly, Pax7 + cells that did not express another myogenic commitment marker, Myod, were observed (data not shown). Furthermore, these Pax + cells did not express the downstream differentiation markers Myogenin and Myosin heavy chain (Fig. 1F,G (Fig. 1B) . Since skeletal muscle is a potent source of signaling molecules, we asked if differentiated muscle is necessary for the mobilization of these Pax + cells from the central dermomyotome. In Myf5 nlacZ/nlacZ embryos, the early myotome is absent (Fig. 1C ,E,H), and it is initiated by Myod from E11.5 (Tajbakhsh et al. 1997) − population becomes distributed among skeletal muscle masses in the trunk and limbs after the disappearance of the dermomyotome. This novel population might represent a persistent stem cell pool that gives rise to muscle progenitors during development. At later stages, fetal myoblasts emerge, and their relationship with embryonic MPCs and myoblasts remains controversial (Harris et al. 1989; Cusella-De Angelis et al. 1994; Evans et al. 1994; Tajbakhsh 2003) . To investigate this issue further, we examined mouse mutants in which the biphasic prenatal myogenic program is uncoupled genetically.
Uncoupling embryonic from fetal myogenesis unveils muscle progenitors and their ancestors
Remarkably, Myf5:Myod double mutants, generated with either Myf5 loxP or Myf5 GFP-P alleles, make embryonic (Kassar-Duchossoy et al. 2004 ) but not fetal muscles ( Fig. 2A ; data not shown). Therefore, Mrf4 can determine muscle progenitor cell identity in the embryo, but not in the fetus. In keeping with this notion, Mrf4 nlacZ is expressed in the dermomyotome of normal embryos (Kassar-Duchossoy et al. 2004) , and Pax3 and Mrf4 proteins are coexpressed in embryonic progenitors in the dermomyotome in double mutants (Fig. 2C) . Furthermore, ␤-gal from the Mrf4 nlacZ knock-in was not coexpressed with Pax7 in the fetus (Fig. 2D, top) . Moreover, expression of the early differentiation marker Myogenin preceded that of Mrf4 nlacZ in the fetus (Fig. 2D, bottom) . Thus, Mrf4 is expressed in differentiated cells and is not detected in fetal MP F Cs, consistent with the finding that fetal muscles are lacking in Myf5:Myod double mutants. These observations demonstrate that MP F Cs in the fetus are genetically distinct from embryonic MP E Cs with respect to their requirement for, or expression of, Mrf4 (Fig. 2E) .
We then investigated the relationship between the Pax + cells, progenitors, and precursors in the fetus. Not all Pax + cells derived from the dermomyotome give rise to skeletal muscle (Christ and Ordahl 1995; Kardon et al. 2002) , therefore it is important to determine if resident Pax + cells are in the muscle lineage. Antibody stainings for the endothelial marker PECAM failed to detect coexpression with Pax7 in emerging muscle masses, suggesting that the Pax + cells residing in muscle are not in the endothelial lineage (data not shown). In addition, in the chick, Pax7 is not coexpressed with the connective tissue marker TCF4 (Kardon et al. 2003) . Figure 3A shows that Pax7
− and Pax7 + /Myf5 + cells reside in fetal muscles. This suggests that as in the embryo, they form a lineage continuum. Accordingly, the majority of 
fetuses (arrowhead). GFP autofluorescence from Myf5
GFP-P is not detected under these fixation conditions. (F) Scheme indicating that differentiating skeletal muscles are required for maintenance of the primitive myogenic cells. Bars, 10 µM.
Pax7
+ cells activate Myf5 as development proceeds (see below), and they are monodispersed and intimately associated with muscle fibers (Figs. 2D [top] , 3B). Furthermore, as observed in the embryo (Fig. 1G) , Pax expression was down-regulated during committment and differentiation. Since muscle progenitors transit to myoblasts rapidly, it was difficult to distinguish the different myogenic cell populations in the fetus. Therefore, it is desirable to block muscle commitment and investigate the remaining undetermined myogenic cells. To do this, we examined Pax3 Sp/Sp :Myf5 nlacZ/nlacZ mutants in which embryonic and fetal myogenesis are compromised in the body (Tajbakhsh et al. 1997) , and Myf5
GFP-P/GFP-P :Myod
−/− mutants, in which fetal myogenesis is compromised (Fig. 2A) . In both models, undifferentiated Desmin + cells were not observed in the late fetus, indicating that fetal myoblasts are absent (Table 1 ; Supplementary Fig. 3B,C) . Figure 3C shows that Pax7
− as well as Pax7 + /Myf5 + cells were detectable in the absence of myoblasts. They appeared in close proximity, and in some cases the Pax + cells were associated with residual Desmin + differentiated embryonic fibers ( Fig. 3B; Supplementary Fig. 3A ). By analogy with the embryo, we propose that Pax − ancestors (Fig. 1B) . Taken together, these observations suggest that MP F Cs observed in the fetus are generated independently from MP E Cs, presumably from persistent Pax + /MRF − cells. Alternatively, MP E Cs would persist during fetal stages, and thereafter down-regulate Mrf4 expression (Fig. 2E) . The latter is less likely since activation of the myogenic factors is generally associated with rapid acquisition of a myoblast identity (Molkentin and Olson 1996; Tajbakhsh and Buckingham 2000) . Furthermore, we observe proliferating Pax + cells seeded in muscle masses throughout development. As in the embryo, a progressive loss of Pax expression was concomitant with a gain in ␤-gal expression in normal and mutant fetuses, thereby favoring the idea of myogenic progression from Pax (Table 1 ). These observations suggest that in the latter, embryonic muscles sustain the primitive myogenic cells.
To investigate the mechanism of this loss, we assayed for the expression of the activated form of Caspase3, an early marker for apoptosis. Unlike normal fetuses, in the trunk and limbs of double mutants, we observed high numbers of apoptotic cells in presumed muscle-forming regions, as identified by Pax7 protein or Myf5 reporter gene expression (Fig. 3D,E) . Surprisingly, Pax7 and activated Caspase3 were not coexpressed in double mutants lacking muscle (<1%; n = 500 Pax7 + cells) or controls (<1%; n = 400 Pax7 + cells). In contrast, a significantly high proportion of Myf5 + cells coexpressed this marker (at least 20%; n = 90 GFP + cells) ( Fig. 3E ; Supplementary  Fig. 3B ,C; fetal progenitors and embryonic differentiated cells) compared with controls (<1%, n = 1000 cells). This finding demonstrates that Pax7 + cells are refractory to apoptosis. We suggest that during lineage progression in these mutants, Pax7 protein levels decline after Myf5 expression ( Fig. 3A; Supplementary Fig. 1A ; data not shown). In the absence of Myf5 and Myod proteins, these progenitors are subsequently lost by programmed cell death, or they change fate . Thus, these findings identify differentiating skeletal muscle as a critical mediator of the survival of myogenic stem/ progenitor cells by maintaining Pax7 expression, probably via paracrine mechanisms.
Persistent Pax + cells mark emerging satellite cells, and they do not require Pax3 function
The origins of satellite cells have been the subject of much debate (Zammit and Beauchamp 2001; Parker et al. 2003; Tajbakhsh 2003 ). Since we observed that proliferating Pax + cells reside in muscle throughout development ( Fig. 4A,B; Supplementary Fig. 1C,D) , we asked if they would persist until birth, and how this population relates to satellite cells. At later fetal stages, Pax7 + cells persisted, whereas Pax3 for the most part was downregulated in these cells (Fig. 4 ; data not shown). Figure  2D shows that Pax7 + cells are loosely associated with differentiating muscle fibers at E15.5. By E16.5 they were located underneath a basal lamina and were situated outside the fiber (Fig. 4A,B) , a characteristic feature of satellite cells (Zammit and Beauchamp 2001 fetal myoblasts ( Fig. 4C,D ; data not shown). Interestingly, by birth we observed that some Pax7 + satellite cells remained negative for, or expressed low levels of, Myf5 nlacZ (Fig. 4C,D) . Albeit, >99% of Pax7 + cells expressed Myf5 around birth (data not shown). These findings suggest that Pax + /MRF − cells in the fetus are distinct from fetal progenitors and committed precursors, and are lineage descendants of the dermomyotome. Strikingly, Pax7 + satellite cells were absent at birth in mutants lacking skeletal muscles (Table 1 ). Taken together, these observations strongly suggest that satellite cells arise from the resident Pax + cells that we identify, thereby supporting the argument against an independent lineage origin for satellite cells.
Pax3 plays a critical role in myogenesis since Pax3-null mice lack migratory muscle progenitors, and mice null for Pax3, Myf5, and Mrf4 fail to activate Myod in the body (Tajbakhsh et al. 1997; Kassar-Duchossoy et al. 2004 ). In addition, dermomyotome integrity is compromised in Pax3-null embryos, whereas Pax7 mutants do not display overt prenatal muscle deficiencies (Mansouri et al. 1996) . Since most Pax3-null mice die by E14.5, the role of Pax3 in fetal muscle development has not been evaluated. We asked whether Pax3 function is required for the emergence of uncommitted Pax + cells in the embryo, or their maintenance. Analysis of Pax3
Sp/Sp mutants at E11.5 revealed that Pax7 + cells penetrated the myotome as observed in normal embryos (Fig. 1D,F The classification of different cell states in muscle, notably the identification of a novel uncommitted Pax3/ Pax7 + population, provides a framework for refining the cell order in this lineage, and characterizing the skeletal muscle niche. Moreover, we propose that differentiated skeletal muscle or precursor cells are a functional component of this niche since Pax7 + stem cells, as well as MPCs, require the downstream myogenic program for their self-renewal, but surprisingly, not for their birth (Figs. 1E, 3F) . In future studies it would important to identify factors secreted by skeletal muscle that will mediate the self-renewal of engrafted cells, and thereby enhance their regenerative potential.
Materials and methods
Preparation of embryos
Mouse mutants were genotyped and interbred, and embryos were prepared as described previously (Kassar-Duchossoy et al. 2004) . Briefly, embryos were fixed in 4% paraformaldehyde, embedded in 15% sucrose/ 7% gelatin or in 30% sucrose, and frozen in liquid nitrogen or isopentane. Cryostat sections 10-20 µm were treated with antibodies or stained with X-gal (Tajbakhsh et al. 1997 ). . Amplification of some monoclonal antibodies was done using a biotin-conjugated anti-mouse antibody (1/1000) followed by Cy3-conjugated Strepavidin (1/2000, Jackson Immunoresearch). All images on sections were acquired with an Apotome-equipped Zeiss Axioplan and Axiovision software. Optical slice views (0.7-1.1 µm) were reconstructed from fluorescent samples, using a series of grid projections. All images were assembled in Adobe Photoshop.
Immunofluorescence and imaging
Single fiber preparations
Single fibers were prepared as described previously (Zammit et al. 2002) . Briefly, after removal of the skin, forelimbs of newborn pups were digested for 45 min with 0.1% type I collagenase (Sigma) in DMEM. Single myofibers were released by trituration of the limb with a Pasteur pipette, and fibers were fixed immediately in 1% PFA for 15 min, rinsed in PBS, and prepared for immunostaining.
Western blot MRF-expressing vectors (EMSV-Myf5, EMSV-Myod, EMSV-Myogenin, and EMSV-Mrf4) were transiently transfected in HEK293T cells with Lipofectamine 2000, according to the manufacturer's instructions (Invitrogen) as described (Kassar-Duchossoy et al. 2004) . After 48 h, cells were lysed and processed with antibodies (anti Myf-5, C-term, 1/500; antiMyod, full length, 1/200; anti-Myogenin, full length, 1/400; and antiMrf4, C-term, 1/500; Santa Cruz). :Myf5 nlacZ/+ mutant. Some remain X-gal (dark nuclei) negative (arrowhead). Bars, 10 µM.
